| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2001;103:269.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Pathology (C.B., L.R., G.T.) and Cardiology (D.C.), University of Padua Medical School, Padua, Italy.
Correspondence to Gaetano Thiene, MD, FESC, FEACTS, Istituto di Anatomia Patologica, Via A. Gabelli 61, 35121 Padova, Italy. E-mail cardpath{at}ux1.unipd.it
BackgroundSudden death (SD) in ventricular preexcitation (VP) syndrome is believed to be the result of atrial fibrillation with rapid ventricular response over the accessory pathway. Previous reports are anecdotal and often lack autopsy validation.
Methods and
ResultsPrevalence and clinicopathological
features of VP were investigated in a series of 273 SDs in children and
young adults (aged
35 years). Site of accessory atrioventricular (AV)
connection was predicted by 12-lead ECG. Right and left AV ring
together with the sinoatrial and AV septal junction were studied in
serial histological sections. Ten patients (3.6%; male, mean age 24±7
years) had VP: 8 had Wolff-Parkinson-White (WPW) and 2 had
Lown-Ganong-Levine (LGL) syndrome. Six patients had previous symptoms,
and SD occurred at rest in all but 1. Pathological substrates of LGL
consisted of AV-node hypoplasia and right-sided atrio-Hisian tract,
respectively. In the 8 WPW patients, 10 total accessory AV pathways
consisting of ordinary myocardium were found (7 left lateral, 2 right
posterolateral, and 1 septal). These pathways were close to the
endocardium (mean distance, 750±530 µm) and 310±190 µm thick. In
4 WPW patients (50%), isolated acute atrial myocarditis was found,
which was polymorphous in 1 and lymphocytic in
3.
ConclusionsVP accounted for 3.6% of SD in young people and was not preceded by warning symptoms in 40%. A left accessory pathway was the most frequent substrate, and its subendocardial location supports the feasibility of catheter ablation. Isolated atrial myocarditis may act as a trigger of paroxysmal atrial fibrillation that leads to SD.
Key Words: atrium death, sudden myocarditis pathology Wolff-Parkinson-White syndrome
This article has been cited by other articles:
![]() |
J. K Triedman Management of asymptomatic Wolff-Parkinson-White syndrome Heart, October 1, 2009; 95(19): 1628 - 1634. [Full Text] [PDF] |
||||
![]() |
J.#x.;n. Farré, H. J.J. Wellens, J.#x. M. Rubio, and J. Benezet CHAPTER 28 Supraventricular Tachycardias ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corrado, C. Basso, A. Pelliccia, and G. Thiene CHAPTER 32 Sports and Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Ho Accessory Atrioventricular Pathways: Getting to the Origins Circulation, March 25, 2008; 117(12): 1502 - 1504. [Full Text] [PDF] |
||||
![]() |
O. A. Centurion, A. Shimizu, S. Isomoto, and A. Konoe Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff--Parkinson--White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway Europace, March 1, 2008; 10(3): 294 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Chiale, E. Albino, H. A. Garro, H. Selva, R. J. Levi, R. A. Sanchez, M. V. Elizari, and C. B. Alvarez Supernormal Conduction in the Anomalous Bundles of the Wolff-Parkinson-White Syndrome: An Overlooked Electrophysiologic Property With Potential Clinical Implications Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 181 - 191. [Abstract] [PDF] |
||||
![]() |
D. Corrado, C. Basso, A. Pavei, P. Michieli, M. Schiavon, and G. Thiene Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program JAMA, October 4, 2006; 296(13): 1593 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pieroni, C. Chimenti, A. Frustaci, K. Nanthakumar, Y. R. Lau, V. J. Plumb, A. E. Epstein, and G. N. Kay Letter Regarding Article by Nanthakumar et al, "Electrophysiological Findings in Adolescents With Atrial Fibrillation Who Have Structurally Normal Hearts" * Response Circulation, January 25, 2005; 111(3): e27 - e27. [Full Text] [PDF] |
||||
![]() |
K. Kumagai, H. Nakashima, and K. Saku The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model Cardiovasc Res, April 1, 2004; 62(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lavi, A. Shainberg, H. Friedmann, V. Shneyvays, O. Rickover, M. Eichler, D. Kaplan, and R. Lubart Low Energy Visible Light Induces Reactive Oxygen Species Generation and Stimulates an Increase of Intracellular Calcium Concentration in Cardiac Cells J. Biol. Chem., October 17, 2003; 278(42): 40917 - 40922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arad, I. P. Moskowitz, V. V. Patel, F. Ahmad, A. R. Perez-Atayde, D. B. Sawyer, M. Walter, G. H. Li, P. G. Burgon, C. T. Maguire, et al. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy Circulation, June 10, 2003; 107(22): 2850 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pappone, V. Santinelli, S. Rosanio, G. Vicedomini, S. Nardi, A. Pappone, V. Tortoriello, F. Manguso, P. Mazzone, S. Gulletta, et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: Results from a large prospective long-term follow-up study J. Am. Coll. Cardiol., January 15, 2003; 41(2): 239 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Gollob, J. J. Seger, T. N. Gollob, T. Tapscott, O. Gonzales, L. Bachinski, and R. Roberts Novel PRKAG2 Mutation Responsible for the Genetic Syndrome of Ventricular Preexcitation and Conduction System Disease With Childhood Onset and Absence of Cardiac Hypertrophy Circulation, December 18, 2001; 104(25): 3030 - 3033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |